Nuclear matrix protein 22 (NMP22) in the follow-up of superficial transitional carcinoma of the urinary bladder

Home

Pages

Renal medicine

Add annotation to this page

Authoring team

nuclear matrix protein 22 (NMP-22) is a nuclear matrix apparatus protein that is involved in the proper distribution of chromatids to daughter cells during cellular replication

study evidence has shown that the addition of NMP-22 testing of voided urine to cytology increases the sensitivity for recurrence detection in patients with superficial transitional cell bladder cancer (1)

Gupta NP et al. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder.Urology. 2009 Mar;73(3):592-6

Annotations let you add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. Reflective notes let you add information to the CPD dashboard based on the content of this page: what did you learn from it and how might it change your practice?

Annotations let you add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

Nuclear matrix protein 22 (NMP22) in the follow-up of superficial transitional carcinoma of the urinary bladder

Related pages

Create an account to add page annotations